KARACHI: The cure discovered by Pakistani scientists of Dow University of Health Sciences (DUHS) for coronavirus awaits approval of the Drug Regulatory Authority of Pakistan (DRAP), Dialogue Pakistan has learnt on Wednesday.
Talking to Dialogue Pakistan, DUHS Spokesman Naeem Tahir said that the faculty members of the university had completed trial of the treatment on animals and found it completely satisfactory. He said it was a standard procedure to test a treatment or a drug on animals before testing them on human beings. He said in 90 percent of the cases the treatment was effective on human beings also if it positively affected animal health.
To a query, he said that health experts all over the world were trying to find the cure but the Pakistani scientists have successfully developed intravenous immunoglobulin (IViG) to defeat coronavirus. He said SARS and Ebola patients were also recovered through IViG treatment after the diseases’ antibodies were developed.
Naeem Tahir said it would be criminal if they tested the treatment on human beings without taking approval from the DRAP. A formal request had been forwarded to the regulatory authority in this regard, he said adding that a response was anticipated in a couple of next days.
On April 13, Pakistani scientists had claimed to have made a significant success in the fight against coronavirus pandemic.
Medical sciences experts at Dow University Health Sciences had claimed to have developed intravenous immunoglobulin (IVIg) which would be able to cure a coronavirus patient. The IVIG had been prepared using antibodies from body of the patients who recovered from the viral infection.
Prof Shaukat had said preparation of immunoglobulin was a ray of hope amid the coronavirus crisis.
Vice Chancellor Prof Muhammad Saeed Quraishy had described it as a very important breakthrough in the war against Covid19.
“This way of treatment is a safe, low risk and highly effective against Coronavirus. Through this method, Immunoglobulin is prepared after separation of antibodies found in the blood of a recovered patient from the corona. This method is considerably different from plasma therapy and it should be noted that the treatment by hyper immunoglobulin (H-IVIG) is approved by the US Federal agency, Food and Drug Administration (FDA), for normal conditions. Plasma therapy, on the other hand, is only allowed in emergencies due to its side effects,” he had said.